Literature DB >> 17108327

The extracellular linker of pro-neuregulin-alpha2c is required for efficient sorting and juxtacrine function.

Juan C Montero1, Ruth Rodríguez-Barrueco, Laura Yuste, Pedro P Juanes, Joana Borges, Azucena Esparís-Ogando, Atanasio Pandiella.   

Abstract

The neuregulins (NRGs) play important roles in animal physiology, and their disregulation has been linked to diseases such as cancer or schizophrenia. The NRGs may be produced as transmembrane proteins (proNRGs), even though they lack an N-terminal signal sequence. This raises the question of how NRGs are sorted to the plasma membrane. It is also unclear whether in their transmembrane state, the NRGs are biologically active. During studies aimed at solving these questions, we found that deletion of the extracellular juxtamembrane region termed the linker, decreased cell surface exposure of the mutant proNRG(DeltaLinker), and caused its entrapment at the cis-Golgi. We also found that cell surface-exposed transmembrane NRG forms retain biological activity. Thus, a mutant whose cleavage is impaired but is correctly sorted to the plasma membrane activated ErbB receptors in trans and also stimulated proliferation. Because the linker is implicated in surface sorting and the regulation of the cleavage of transmembrane NRGs, our data indicate that this region exerts multiple important roles in the physiology of NRGs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108327      PMCID: PMC1783780          DOI: 10.1091/mbc.e06-06-0511

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  61 in total

Review 1.  Protein folding and quality control in the endoplasmic reticulum.

Authors:  Bertrand Kleizen; Ineke Braakman
Journal:  Curr Opin Cell Biol       Date:  2004-08       Impact factor: 8.382

2.  The cytoplasmic carboxy-terminal amino acid specifies cleavage of membrane TGF alpha into soluble growth factor.

Authors:  M W Bosenberg; A Pandiella; J Massagué
Journal:  Cell       Date:  1992-12-24       Impact factor: 41.582

3.  Transmembrane TGF-alpha precursors activate EGF/TGF-alpha receptors.

Authors:  R Brachmann; P B Lindquist; M Nagashima; W Kohr; T Lipari; M Napier; R Derynck
Journal:  Cell       Date:  1989-02-24       Impact factor: 41.582

Review 4.  Signal transduction by receptors with tyrosine kinase activity.

Authors:  A Ullrich; J Schlessinger
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

5.  The TGF-alpha precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction.

Authors:  S T Wong; L F Winchell; B K McCune; H S Earp; J Teixidó; J Massagué; B Herman; D C Lee
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

6.  Identification of heregulin, a specific activator of p185erbB2.

Authors:  W E Holmes; M X Sliwkowski; R W Akita; W J Henzel; J Lee; J W Park; D Yansura; N Abadi; H Raab; G D Lewis
Journal:  Science       Date:  1992-05-22       Impact factor: 47.728

7.  Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor alpha to epidermal growth factor receptors promotes cell proliferation.

Authors:  P Anklesaria; J Teixidó; M Laiho; J H Pierce; J S Greenberger; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells.

Authors:  E Peles; S S Bacus; R A Koski; H S Lu; D Wen; S G Ogden; R B Levy; Y Yarden
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

9.  Membrane-anchored forms of EGF stimulate focus formation and intercellular communication.

Authors:  Y Dobashi; D F Stern
Journal:  Oncogene       Date:  1991-07       Impact factor: 9.867

10.  Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells.

Authors:  J Massagué
Journal:  J Biol Chem       Date:  1983-11-25       Impact factor: 5.157

View more
  8 in total

1.  Transautocrine signaling by membrane neuregulins requires cell surface targeting, which is controlled by multiple domains.

Authors:  Juan Carlos Montero; Ruth Rodríguez-Barrueco; Atanasio Pandiella
Journal:  J Biol Chem       Date:  2011-05-13       Impact factor: 5.157

Review 2.  Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Authors:  Chao Deng; Bo Pan; Martin Engel; Xu-Feng Huang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

Review 3.  Neuregulin 1 in neural development, synaptic plasticity and schizophrenia.

Authors:  Lin Mei; Wen-Cheng Xiong
Journal:  Nat Rev Neurosci       Date:  2008-05-14       Impact factor: 34.870

4.  Breast cancer dissemination promoted by a neuregulin-collagenase 3 signalling node.

Authors:  S Seoane; J C Montero; A Ocaña; A Pandiella
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

5.  PDCD4 limits prooncogenic neuregulin-ErbB signaling.

Authors:  Juan Carlos Montero; Atanasio Pandiella
Journal:  Cell Mol Life Sci       Date:  2020-08-17       Impact factor: 9.261

6.  Neuregulin 1 expression and electrophysiological abnormalities in the Neuregulin 1 transmembrane domain heterozygous mutant mouse.

Authors:  Leonora E Long; Paul Anderson; Elisabeth Frank; Alex Shaw; Shijie Liu; Xu-Feng Huang; Didier Pinault; Tim Karl; Terence J O'Brien; Cynthia Shannon Weickert; Nigel C Jones
Journal:  PLoS One       Date:  2015-05-19       Impact factor: 3.240

7.  The immunoglobulin-like domain of neuregulins potentiates ErbB3/HER3 activation and cellular proliferation.

Authors:  Ariana Centa; Ruth Rodríguez-Barrueco; Juan Carlos Montero; Atanasio Pandiella
Journal:  Mol Oncol       Date:  2018-05-14       Impact factor: 6.603

Review 8.  MiRNAs, lncRNAs, and circular RNAs as mediators in hypertension-related vascular smooth muscle cell dysfunction.

Authors:  Ji-Ru Zhang; Hai-Jian Sun
Journal:  Hypertens Res       Date:  2020-09-23       Impact factor: 3.872

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.